The percentage of apoptotic fibroblasts in keloids and normal skins increased from 3.31% 0.46% to 18.6% 9.44% and from 5.51% 3.34% to 25.42% 5.82%, respectively ( p = 0.04 and p = 0.01, respectively
We'll evaluate your history, screen for contraindications, and recommend the right dose
GHK-Cu adds another layer of concern because FDA has specifically discussed immunogenicity risk for injectable GHK-Cu related to potential aggregation and peptide-related impurities
A peptide serum can therefore function as a supportive daily treatment that helps keep the skin comfortable, hydrated, and balanced
Typically, you would apply a GHK-Cu product once or twice a day as part of your regular skincare routine
BPC-157 Tablets: Do Oral Forms Work